© 2020 MJH Life Sciences and Managed Healthcare Executive. All rights reserved.
Multiple Sclerosis
Siponimod Enters Crowded Market of DMTs for SPMS
June 04, 2020
The Institute for Clinical and Economic Review (ICER) found siponimod has benefits for patients with active secondary progressive multiple sclerosis, but its benefits were in line with other therapies in a crowded marketplace.
In Secondary-Progressive Multiple Sclerosis, Questions Abound, But So Do Breakthroughs
June 04, 2020
Much remains unknown about how precisely multiple sclerosis occurs and advances in patients, but a growing body of research is helping scientists develop new ways to slow, and potentially stop, disease progression.
Breakthrough Therapies, Opportunities for Savings in Near-term Specialty Pipeline
November 21, 2019
As more competition makes its way into the specialty drug market, there will be opportunities for cost savings.
Specialty Medications and Managed Care Pharmacy
October 18, 2019
At AMCP Nexus 2019, experts weigh in on new and emerging specialty medications.
What’s New in the MS Drug Pipeline
August 09, 2019
MS is in need of new medications-these could be the future.